132
Participants
Start Date
April 30, 2015
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2030
Paclitaxel
Patients receive paclitaxel 175mg/㎡ IV over 3 hours on day 1. Treatment repeats every 21 days for 4-6 courses in the absence of disease progression or unacceptable toxicity.
Carboplatin
and carboplatin AUC 5-6 IV over 1 hour on day 1. Treatment repeats every 21 days for 4-6 courses in the absence of disease progression or unacceptable toxicity.
Bleomycin
Bleomycin 30000IU IM per day for 3 days every 3 weeks for 3-4 cycles.
Etoposide
Etoposide 100mg/㎡ IV per day for 5 days every 3 weeks for 3-4 cycles.
Cisplatin
Cisplatin 20mg/㎡ IV per day for 5 days every 3 weeks for 3-4 cycles in the absence of disease progression or unacceptable toxicity.
RECRUITING
Qilu Hospital of Shandong University, Jinan
Huazhong University of Science and Technology
OTHER
Zhejiang University
OTHER
Sun Yat-sen University
OTHER
Beihua Kong
OTHER